---  
layout: startup_page  
title: "Alamar Biosciences"  
id: "alamarbio.com"  
permalink: "/alamarbiosciencesalamarbio.com02262024/"  
website: "https://www.alamarbio.com/"  
funding_round: "Series C"  
funding_amount: "$128M"  
investors: "Sands Capital"  
about: "Alamar Biosciences is a life sciences company focused on precision proteomics for early disease detection. Their proprietary NULISA Platform and ARGO HT System offer high-sensitivity protein detection, enabling biomarker discovery and non-invasive disease testing. This technology surpasses existing methods in sensitivity and dynamic range."  
markets: "Biotechnology, Proteomics, Health Care, Medical, Diagnostic Equipment, Decision/Risk Analysis"  
hq: "Fremont, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/alamar-biosciences-inc"  
twitter: "https://twitter.com/AlamarBio"  
instagram: ""  
facebook: "https://www.facebook.com/AlamarBio"  
crunchbase: "https://www.crunchbase.com/organization/alamar-biosciences"  
pitchbook: "https://pitchbook.com/profiles/company/437286-52"  

date_display: "26-Feb-2024"  
date: "2024-02-26"

# SEO Optimization  
meta_title: "Alamar Biosciences - Series C Funding ($128M)"  
meta_description: "Alamar Biosciences, Alamar Biosciences is a life sciences company focused on precision proteomics for early disease detection. Their proprietary NULISA Platform and ARGO ..."  
meta_keywords: "Alamar Biosciences, Biotechnology, Proteomics, Health Care, Medical, Diagnostic Equipment, Decision/Risk Analysis, Series C funding"  
canonical_url: "https://startup.projectstartups.com/alamarbiosciencesalamarbio.com02262024/"  
---